Jamie C. Barner, Ph.D., FAACP, FAPhA

Selected Recent Publications
*Denotes student(s)/trainee(s) at the time of the study.

CORE Research Area: Patient-Centered Outcomes Research

Lim H,* Barner JC. Impact of a workshop on student pharmacist confidence and comfort in counseling patients at risk for maternal mortality. Currents in Pharmacy Teaching and Learning. 2022;14(1):71-82.

Alshehri A,* Barner JC, Wong SL, Ibrahim K, Qureshi S. Perceptions among Muslims regarding fasting, medication use, and provider engagement during Ramadan. International Journal of Health Planning and Management. 2021;36:945-957.

Bamgbade BA,* Barner JC, Ford KH, Brown CM, Lawson WB, Burdine K. Willingness to seek help for depression in young African American adults: protocol for a mixed methods study. Journal of Medical Internet Research Protocol. 2020;9(2):e16267.

Paranjpe R,* Johnson ML, Essien EJ, Barner JC, Serna O, Gallardo E, Majd Z, Fleming ML, Ordonez N, Holstad MM, Abughosh SM. Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs). Patient Preference and Adherence. 2020;14:1935-1947.

Zhang H,* Barner JC, Moczygemba LR, Rascati KL. Assessment of basal insulin adherence using two methodologies among Texas Medicaid enrollees with type 2 diabetes. Journal of Managed Care & Specialty Pharmacy. 2020 Nov;26(11):1434-1444.

CORE Research Area: Healthcare Systems Research

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN.  Examination of barriers to medication adherence, asthma management, and control among community pharmacy patients with asthma. Journal of Pharmacy Practice 2021;34:(4):515-522.

Nduaguba SO,* Barner JC,, Makhinova T,* Roberson K. Medication therapy management for Texas Medicaid patients with asthma and chronic obstructive pulmonary disease – a pilot study. Journal of Pharmacy Practice. 2021 doi:10.1177/0897190021997032.

Shin J,* Moczygemba LR, Barner JC,, Garza A, Linedecker S, Srinivasa M. Patient experience with clinical pharmacist services in Travis county federally qualified health centers. Journal of Pharmacy Practice. 2020;18(2):1751.

Thurman W, Moczygemba LR, Barner JC,.  Priority community engagement strategies for pharmacists to advance cardiovascular health. Journal of the American Pharmacists Association. 2020;60(6):e133-e139.

Peterson J,* Barner JC, Lai P, Hinds A, Garza A, Nguyen M, Hill L, Gums T. Impact of physician-pharmacist co-visits at a primary care clinic in patients with uncontrolled diabetes. Journal of Pharmacy Practice 2020 Jun;33(3):321-325.

CORE Research Area: Health Economics and Outcomes Research

Zhang H,* Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017. Breast Cancer Research and Treatment. 2022 doi 10.1007/s10549-022-06604-5.

Shukla N,* Barner JC, Lawson K, Rascati KL. Age-related healthcare services utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Pharmaceutical Health Services Research. 2021;12:523-530.

Shukla N,* Barner JC, Rascati KL, Lawson K. Age-related prescription medication utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Opioid Management. 2021;174(4):301-310.

Chen S,* Barner JC, Cho E. Off-label antipsychotic use patterns among Texas Medicaid adults 2013-2016. Journal of Comparative Effectiveness Research. 2021 Oct;10(14):1045-1053.

Chen S,* Barner JC, Cho E. Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016. Journal of Managed Care and Specialty Pharmacy 2021;27(8):1035-1045.

Graduate Courses
PGS 196S Seminar in Pharmacy (Topics: Healthcare Databases, Patient Reported Outcomes, Patient Experience)

PGS 390K Experimental Design and Research Methods in Health Care (Topics: Research Designs, Threats to Internal and External Validity, Power Analysis)

PGS 390J Data Analysis in Health Care (Topics: Coding, SAS)

PGS 390U Advanced Research Methods (Topics: Medication Adherence, Network Meta-Analysis, Logistic Regression, Patient Experience)

PharmD Courses
PHM 384L Pharmacy and the U.S. Health Care System (Topics: Utilization and Costs, Access to Care, Fraud and Abuse, Health Care Manpower, Hospitals, Long Term Care, Pharmaceutical Industry, Pharmacies)

PHM 394F Principles of Pharmacoeconomics and Pharmacy Management (Topics: Human Resources Management, Health Information Technology, Risk Management)

Significant/Recent Activities

National and International Service Activities

American Association of Colleges of Pharmacy
2021-2022, Past Chair, Social and Administrative Sciences Section

2021-2022, Chair, Nominations Committee

2021-2022, Chair, New Investigator Award Committee

2020-present, Member, Gender Equity Task Force; Joint Effort with APhA

2020-2021, Chair, Social and Administrative Sciences Section

2019-2020, Chair, Annual Program Committee

American Pharmacists Association
2020-present Member, Gender Equity Task Force; Joint Effort with AACP

2020, Member, Assessing the Needs of Scientists in the Profession Working Group

2020, Member, Assessing the Needs of Scientists in the Profession Focus Group

2019, Judge, Podium Presentations at the 2019 Annual Meeting

University/College Service Activities
University
2019, Member, Consultative Committee for the Selection of a new Dean of the College of Pharmacy

2018-present Member, Texas Exes Scholarship Advisory Committee

2018-2020, Member, Faculty Council, College of Pharmacy Representative

2018-2020, Member, C-10 Recruitment and Retention Committee

College of Pharmacy
2022- present, Member, Graduate Affairs and Curriculum Committee

2020-present, Advisory Board Member, Build Our Own Talent (BOOT) Program

2019-present, Member, Academic Support Committee

2018-present, Member, Academic Performance Committee

2017-present, Member, Staff Development and Wellness Committee

2017-present, Member, Diversity Equity, Accessibility, and Inclusion Committee

2015-present, Member, Translation Science PhD Committee on Graduate Studies

2009-present, PharmD/PhD Oversight Committee

2000-present, Co-Advisor, Student National Pharmaceutical Association

Centers for Disease Control Grants

• Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke CDC-RFA-DP18-1815
• Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke CDC-RFA-DP18-1817
  • Barner JC, Moczygemba LR, Davis P, Cuevas J, George E, Rush S, Travillion P,* Clague M,* “Impact of a medication therapy management workshop on student pharmacists’ confidence in engaging providers in collaboration: results from four institutions” at the American Pharmacists Association Annual Meeting, San Antonio, TX, March 18-21, 2022. (Podium)
  • Moczygemba LR, Barner JC, Tucker A, McNabb, Miller A,* “Implementation and perceptions of a program to support diabetes self-management education and support accreditation of Texas pharmacies” at the American Pharmacists Association Annual Meeting, San Antonio, TX, March 18-21, 2022. (Talking Poster)
  • Barner JC, Moczygemba LR, Rush S, Travillion P,* Clague M,* “Medication therapy management and diabetes self-management education and support in Texas colleges/schools of pharmacy” at the American Association of Colleges of Pharmacy Annual Meeting (virtual), July 19-22, 2021.
  • Barner JC, Moczygemba LR, Pope N, Clague M,* Travillion P,* “Medication therapy management and diabetes self-management education and support in Texas community-based pharmacy residency programs” at the American Pharmacists Association Annual Meeting (virtual),  March 12-15, 2021. (Podium)
  • Hudzik A,* Moczygemba LR, Barner JC, Wallace-Gay T, Semwal M, “Texas community pharmacists and MTM services” at the American Pharmacists Association Annual Meeting (virtual),  March 12-15, 2021.
  • Barner JC, Hughes PJ, Moczygemba LR, Pinto S, Sisson E, “Strategies for engaging community partners, healthcare professionals, and students: Research experiences from four institutions” at the American Association of Colleges of Pharmacy Annual Meeting (virtual) July 18-20, 2020. (Podium)

Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Grant

• Predoctoral Fellowship in Health Outcomes Research (Student PI: Hanxi “Molly” Zhang; Co-Faculty PIs: Drs. Barner and Moczygemba)
  • Zhang H,* Barner JC, Moczygemba LR, Rascati K, Park C, Kodali D, “2010–2017 trends of neoadjuvant chemotherapy use among older women with breast cancer: A SEER-Medicare analysis” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 15-18, 2022.
  • Zhang H,* Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017. Breast Cancer Research and Treatment. 2022 doi 10.1007/s10549-022-06604-5.

Novartis (some work unsponsored): Focus on Sickle Cell Disease

• Healthcare Utilization and Costs among Texas Medicaid Patients with Sickle Cell Disease
  • Shukla N,* Barner JC, Rascati KL, Lawson K, “Prescription medication utilization for the management of sickle cell disease by age group” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting (virtual), May 16-20, 2020.
  • Shukla N,* Barner JC, Rascati KL, Lawson K, “Age-related healthcare service utilization in sickle cell disease management” at Academy of Managed Care Pharmacy Annual Meeting (virtual), April 21-24, 2020.
  • Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC, “Association between hydroxyurea medication adherence and all-cause and disease-related healthcare expenditures among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
  • Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between vaso-occlusive crises and opioid use among Texas Medicaid recipients with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
  • Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between hydroxyurea adherence and persistence and vaso-occlusive crises among Texas Medicaid recipients with sickle cell disease” at Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, March 26-28, 2019.
  • Kang HA,* Barner JC, “Hydroxyurea medication adherence and opioid use among Texas Medicaid enrollees with sickle cell disease” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 22-25, 2019.
  • Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC “Association between hydroxyurea medication adherence and vaso-occlusive crisis events among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 19-23, 2018
  • Shukla N,* Barner JC, “Temporal use of medications for the management/treatment of sickle cell disease” at the Academy of Managed Care Pharmacy Annual Meeting, Boston, MA, April 23-26, 2018.